Cargando…

Two Secreted Proteoglycans, Activators of Urothelial Cell–Cell Adhesion, Negatively Contribute to Bladder Cancer Initiation and Progression

SIMPLE SUMMARY: Epithelial–mesenchymal transition (EMT) is associated with cancer progression. Here, we found that two secreted proteins of osteomodulin (OMD) and proline/arginine-rich end leucine repeat protein (PRELP) were selectively expressed in bladder umbrella epithelial cells, and they were s...

Descripción completa

Detalles Bibliográficos
Autores principales: Papadaki, Vasiliki, Asada, Ken, Watson, Julie K., Tamura, Toshiya, Leung, Alex, Hopkins, Jack, Dellett, Margaret, Sasai, Noriaki, Davaapil, Hongorzul, Nik-Zainal, Serena, Longbottom, Rebecca, Nakakido, Makoto, Torii, Ryo, Veerakumarasivam, Abhi, Kaneko, Syuzo, Sagoo, Mandeep S., Murphy, Gillian, Mitani, Akihisa, Tsumoto, Kohei, Kelly, John D., Hamamoto, Ryuji, Ohnuma, Shin-ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697838/
https://www.ncbi.nlm.nih.gov/pubmed/33202923
http://dx.doi.org/10.3390/cancers12113362
Descripción
Sumario:SIMPLE SUMMARY: Epithelial–mesenchymal transition (EMT) is associated with cancer progression. Here, we found that two secreted proteins of osteomodulin (OMD) and proline/arginine-rich end leucine repeat protein (PRELP) were selectively expressed in bladder umbrella epithelial cells, and they were suppressed in bladder cancer. We revealed that OMD(−/−) or PRELP(−/−) knockout mice caused a breakdown of the umbrella cell layer through weakening cell–cell integrity and the activation of partial EMT, which resulted in the formation of early bladder cancer-like structures, while OMD or PRELP application to bladder cancer cells inhibited cancer progression through reversing EMT, which was mediated by the inhibition of TGF-β and EGF. Our result indicates that OMD and PRELP function as tumor-suppressing proteins through inhibiting EMT. OMD and PRELP may be potential therapeutic targets in bladder cancer. ABSTRACT: Osteomodulin (OMD) and proline/arginine-rich end leucine repeat protein (PRELP) are secreted extracellular matrix proteins belonging to the small leucine-rich proteoglycans family. We found that OMD and PRELP were specifically expressed in umbrella cells in bladder epithelia, and their expression levels were dramatically downregulated in all bladder cancers from very early stages and various epithelial cancers. Our in vitro studies including gene expression profiling using bladder cancer cell lines revealed that OMD or PRELP application suppressed the cancer progression by inhibiting TGF-β and EGF pathways, which reversed epithelial–mesenchymal transition (EMT), activated cell–cell adhesion, and inhibited various oncogenic pathways. Furthermore, the overexpression of OMD in bladder cancer cells strongly inhibited the anchorage-independent growth and tumorigenicity in mouse xenograft studies. On the other hand, we found that in the bladder epithelia, the knockout mice of OMD and/or PRELP gene caused partial EMT and a loss of tight junctions of the umbrella cells and resulted in formation of a bladder carcinoma in situ-like structure by spontaneous breakdowns of the umbrella cell layer. Furthermore, the ontological analysis of the expression profiling of an OMD knockout mouse bladder demonstrated very high similarity with those obtained from human bladder cancers. Our data indicate that OMD and PRELP are endogenous inhibitors of cancer initiation and progression by controlling EMT. OMD and/or PRELP may have potential for the treatment of bladder cancer.